Corebridge Financial’s Enliven Therapeutics ELVN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-17,925	Closed	-$353K	–	862
2025 Q1	$353K	Buy	17,925 +425	+2%	+$8.36K	﹤0.01%	1771
2024 Q4	$394K	Sell	17,500 -1,321	-7%	-$29.7K	﹤0.01%	1805
2024 Q3	$481K	Sell	18,821 -116	-0.6%	-$2.96K	﹤0.01%	1757
2024 Q2	$443K	Buy	+18,937	New	+$443K	﹤0.01%	1752